324 related articles for article (PubMed ID: 24194546)
1. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo.
Piao W; Vogel SN; Toshchakov VY
J Immunol; 2013 Mar; 190(5):2263-72. PubMed ID: 23345333
[TBL] [Abstract][Full Text] [Related]
3. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
Toshchakov VU; Basu S; Fenton MJ; Vogel SN
J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
[TBL] [Abstract][Full Text] [Related]
6. TRIF signaling is essential for TLR4-driven IgE class switching.
Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
[TBL] [Abstract][Full Text] [Related]
8. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
9. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
10. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
11. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
12. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling.
Tanimura N; Saitoh S; Matsumoto F; Akashi-Takamura S; Miyake K
Biochem Biophys Res Commun; 2008 Mar; 368(1):94-9. PubMed ID: 18222170
[TBL] [Abstract][Full Text] [Related]
13. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
15. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif.
Kaiser WJ; Offermann MK
J Immunol; 2005 Apr; 174(8):4942-52. PubMed ID: 15814722
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide search of Toll/Interleukin-1 receptor (TIR) domain-containing adapter molecule (TICAM) and their evolutionary divergence from other TIR domain containing proteins.
Verma S; Sowdhamini R
Biol Direct; 2022 Sep; 17(1):24. PubMed ID: 36056415
[TBL] [Abstract][Full Text] [Related]
19. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
Buchholz BM; Billiar TR; Bauer AJ
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
